Vimarsana
Biggest News Aggregation in the World

Page 22 - Jay Olson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Olson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Olson Today - Breaking & Trending Today

Exelixis (EXEL) Q1 2022 Earnings Call Transcript - Vimarsana News

Exelixis (EXEL) Q1 2022 Earnings Call Transcript

EXEL earnings call for the period ending March 31, 2022.

Source: fool.com
Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q1 2022 Results - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NASDAQ:NTLA) Q1 2022 Earnings Conference Call May 05, 2022, 08:00 ET Company Participants Ian Karp - SVP, IR & Corporate Communications John Leonard...

Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript

Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew...

Incyte's (INCY) CEO Hervé Hoppenot on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Incyte's (INCY) CEO Hervé Hoppenot on Q1 2022 Results - Earnings Call Transcript

Incyte Corporation (NASDAQ:NASDAQ:INCY) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET Company Participants Christine Chiou – Head-Investor Relations Hervé Hoppenot – Chairman,...

Sage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Sage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call Transcript

Sage Therapeutics, Inc. (NASDAQ:NASDAQ:SAGE) Q1 2022 Earnings Conference Call May 03, 2022 08:00 AM ET Company Participants Helen Rubinstein - Investor Relations Barry Greene - Chief...